论文部分内容阅读
在医药商业产业利润空间日趋萎缩的市场趋势下,向医药制造尤其是生物医药等上游产业链突进,成为国药股份、上海医药等商业巨头发力的重点。2月28日,上海医药集团股份有限公司(以下简称上海医药)发布公告称,将与复旦张江签订重大新药创制研发战略合作协议,上海医药将在未来
Under the market trend of shrinking profit margins in the pharmaceutical commercial industry, the upstream industry chain such as pharmaceutical manufacturing, especially biomedicine, has become the focus of efforts of commercial giants such as Sinopharm Medicine and Shanghai Pharmaceutical. On February 28, Shanghai Pharmaceuticals Group Co., Ltd. (hereinafter referred to as Shanghai Pharmaceutical) announced that it will sign a strategic cooperation agreement for the research and development of major new drugs with Fudan University, Shanghai Pharmaceutical will be in the future